Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.
OBJECTIVE:
Patients with type 1 diabetes (T1D) have a higher risk of developing chronic kidney disease, cardiovascular events (CVEs), and mortality than the general population. We hypothesized that two previously published biomarkers, namely PRO-C6, a biomarker of collagen type VI formation, and C3…
Journal:
Authors:
- Pilemann-Lyberg S,
- Rasmussen DG,
- Hansen TW,
- Tofte N,
- Winther SA,
- Holm Nielsen S,
- Theilade S,
- Karsdal MA,
- Genovese F,
- Rossing P,
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes
OBJECTIVE:
This study assessed the utility of plasma fragments of propeptides of type III (PRO-C3), V (PRO-C5), and VI (PRO-C6) procollagen for the detection of liver fibrosis in patients with type 2 diabetes mellitus (T2DM).
RESEARCH DESIGN AND METHODS:
Patients with T2DM (n = 191) underwent a…
Journal:
Authors:
- Bril F,
- Leeming DJ,
- Karsdal MA,
- Kalavalapalli S,
- Darb D,
- Lai J,
- Rabe M,
- Cusi K,
Higher collagen VI formation is associated with all-cause mortality in type 2 diabetic patients with microalbuminuria
OBJECTIVE:
Type 2 diabetes is a common risk factor for the development of chronic kidney disease (CKD). Enhanced de novo collagen type VI (COL VI) formation has been associated with renal fibrosis and CKD. We investigated the hypothesis that PRO-C6, a product specifically generated during COL VI fo…
Journal:
Authors:
- Rasmussen DGK,
- Hansen TW,
- von Scholten BJ,
- Nielsen SH,
- Reinhard H,
- Parving HH,
- Tepel M,
- Karsdal MA,
- Jacobsen PK,
- Genovese F,
- Rossing P,